Open Label Study of GSK2402968 in Subjects With Duchenne Muscular Dystrophy
Status:
Terminated
Trial end date:
2014-03-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to explore long-term safety, tolerability and efficacy of
GSK2402968 in DMD subjects who previously participated in either DMD114117 or DMD114044.